itraconazole has been researched along with Nasopharyngeal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Li, X; Wang, Q; Xu, G; Xu, Y | 1 |
| Fong, PH; Lee, VH; Seneviratne, CJ; Wong, SS | 1 |
2 other study(ies) available for itraconazole and Nasopharyngeal Neoplasms
| Article | Year |
|---|---|
Itraconazole attenuates the stemness of nasopharyngeal carcinoma cells via triggering ferroptosis.
Topics: Animals; Cell Line, Tumor; Cell Survival; Female; Ferroptosis; Humans; Itraconazole; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplastic Stem Cells; Radiation Tolerance; Spheroids, Cellular; Xenograft Model Antitumor Assays | 2021 |
Antifungal susceptibility and phenotypic characterization of oral isolates of a black fungus from a nasopharyngeal carcinoma patient under radiotherapy.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Carcinoma; Caspofungin; Chemoradiotherapy; Chemotherapy, Adjuvant; Drug Resistance, Fungal; Echinocandins; Exophiala; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Lipopeptides; Male; Middle Aged; Mouth Diseases; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Opportunistic Infections; Phaeohyphomycosis; Radiotherapy, Intensity-Modulated; Voriconazole | 2015 |